oppenheimer / Заголовки новостей 
Moderna Stock Price $60, MRNA May Climb 80% More, Analyst Indicates
Coinspeaker Moderna Stock Price $60, MRNA May Climb 80% More, Analyst IndicatesThough now Moderna (MRNA) stock is significantly below its ATH, Oppenheimer analyst predicts an 80% increase from the current level. дальше »
2020-6-6 15:15
|
It is Too Early to Consider Bakkt a Flop, Wall Street Analyst Says
Coinspeaker It is Too Early to Consider Bakkt a Flop, Wall Street Analyst SaysBakkt platform was finally launched in September 2019 only to be greeted by a very lukewarm response from investors but analysts from Oppenheimer & Co think that it is too early to write it off. дальше »
2019-10-3 11:03
|
|